Logo image of 5Q5.DE

SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:5Q5 - US8334451098 - Common Stock

189.44 EUR
-4.06 (-2.1%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to 5Q5. 5Q5 was compared to 76 industry peers in the IT Services industry. The financial health of 5Q5 is average, but there are quite some concerns on its profitability. 5Q5 is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year 5Q5 was profitable.
5Q5 had a positive operating cash flow in the past year.
In the past 5 years 5Q5 always reported negative net income.
5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

5Q5 has a Return On Assets of -16.40%. This is amonst the worse of the industry: 5Q5 underperforms 86.84% of its industry peers.
5Q5 has a worse Return On Equity (-63.27%) than 84.21% of its industry peers.
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

With a Gross Margin value of 67.07%, 5Q5 perfoms like the industry average, outperforming 57.89% of the companies in the same industry.
5Q5's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for 5Q5 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 5Q5 remains at a similar level compared to 1 year ago.
5Q5 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 5Q5 has a worse debt to assets ratio.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 5.97 indicates that 5Q5 is not in any danger for bankruptcy at the moment.
5Q5 has a Altman-Z score of 5.97. This is amongst the best in the industry. 5Q5 outperforms 94.74% of its industry peers.
5Q5 has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as 5Q5 would need 2.96 years to pay back of all of its debts.
5Q5's Debt to FCF ratio of 2.96 is fine compared to the rest of the industry. 5Q5 outperforms 60.53% of its industry peers.
A Debt/Equity ratio of 1.07 is on the high side and indicates that 5Q5 has dependencies on debt financing.
5Q5 has a Debt to Equity ratio of 1.07. This is in the lower half of the industry: 5Q5 underperforms 67.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Altman-Z 5.97
ROIC/WACCN/A
WACC8.93%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

A Current Ratio of 1.37 indicates that 5Q5 should not have too much problems paying its short term obligations.
The Current ratio of 5Q5 (1.37) is better than 60.53% of its industry peers.
5Q5 has a Quick Ratio of 1.37. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
5Q5 has a better Quick ratio (1.37) than 64.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 42.53% over the past year.
Measured over the past years, 5Q5 shows a very strong growth in Earnings Per Share. The EPS has been growing by 334.45% on average per year.
The Revenue has grown by 28.48% in the past year. This is a very strong growth!
5Q5 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 68.78% yearly.
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%

3.2 Future

5Q5 is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.25% yearly.
5Q5 is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.92% yearly.
EPS Next Y50.64%
EPS Next 2Y42.47%
EPS Next 3Y41.09%
EPS Next 5Y41.25%
Revenue Next Year29.42%
Revenue Next 2Y26.73%
Revenue Next 3Y25.39%
Revenue Next 5Y23.92%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 5B 10B 15B 20B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 177.05, 5Q5 can be considered very expensive at the moment.
5Q5's Price/Earnings ratio is a bit more expensive when compared to the industry. 5Q5 is more expensive than 72.37% of the companies in the same industry.
5Q5 is valuated expensively when we compare the Price/Earnings ratio to 27.19, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 132.50, which means the current valuation is very expensive for 5Q5.
Based on the Price/Forward Earnings ratio, 5Q5 is valued a bit more expensive than 71.05% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.92. 5Q5 is valued rather expensively when compared to this.
Industry RankSector Rank
PE 177.05
Fwd PE 132.5
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 5Q5 is valued a bit more expensive than 71.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 97.12
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5Q5 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as 5Q5's earnings are expected to grow with 41.09% in the coming years.
PEG (NY)3.5
PEG (5Y)N/A
EPS Next 2Y42.47%
EPS Next 3Y41.09%

0

5. Dividend

5.1 Amount

No dividends for 5Q5!.
Industry RankSector Rank
Dividend Yield 0%

SNOWFLAKE INC

FRA:5Q5 (1/9/2026, 7:00:00 PM)

189.44

-4.06 (-2.1%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-03 2025-12-03/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners73.59%
Inst Owner ChangeN/A
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap64.18B
Revenue(TTM)4.39B
Net Income(TTM)-1.35B
Analysts81.75
Price Target245.64 (29.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.9%
Min EPS beat(2)10.63%
Max EPS beat(2)29.18%
EPS beat(4)4
Avg EPS beat(4)29.73%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)28.63%
EPS beat(12)11
Avg EPS beat(12)66.06%
EPS beat(16)14
Avg EPS beat(16)111.07%
Revenue beat(2)2
Avg Revenue beat(2)1.9%
Min Revenue beat(2)0.66%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.66%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.61%
Revenue beat(12)11
Avg Revenue beat(12)1.2%
Revenue beat(16)15
Avg Revenue beat(16)1.34%
PT rev (1m)-0.2%
PT rev (3m)6.89%
EPS NQ rev (1m)-3.11%
EPS NQ rev (3m)-8.91%
EPS NY rev (1m)1.11%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)1.13%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 177.05
Fwd PE 132.5
P/S 17.03
P/FCF 97.12
P/OCF 85.54
P/B 35.03
P/tB 106.53
EV/EBITDA N/A
EPS(TTM)1.07
EY0.56%
EPS(NY)1.43
Fwd EY0.75%
FCF(TTM)1.95
FCFY1.03%
OCF(TTM)2.21
OCFY1.17%
SpS11.12
BVpS5.41
TBVpS1.78
PEG (NY)3.5
PEG (5Y)N/A
Graham Number11.41
Profitability
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.07%
FCFM 17.54%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 5.97
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)189.07%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y50.64%
EPS Next 2Y42.47%
EPS Next 3Y41.09%
EPS Next 5Y41.25%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%
Revenue Next Year29.42%
Revenue Next 2Y26.73%
Revenue Next 3Y25.39%
Revenue Next 5Y23.92%
EBIT growth 1Y-3.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year254.09%
EBIT Next 3Y82.41%
EBIT Next 5Y66.64%
FCF growth 1Y21.94%
FCF growth 3Y149.6%
FCF growth 5YN/A
OCF growth 1Y21.18%
OCF growth 3Y105.76%
OCF growth 5YN/A

SNOWFLAKE INC / 5Q5.DE FAQ

What is the fundamental rating for 5Q5 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 5Q5.DE.


What is the valuation status for 5Q5 stock?

ChartMill assigns a valuation rating of 1 / 10 to SNOWFLAKE INC (5Q5.DE). This can be considered as Overvalued.


How profitable is SNOWFLAKE INC (5Q5.DE) stock?

SNOWFLAKE INC (5Q5.DE) has a profitability rating of 2 / 10.


What is the valuation of SNOWFLAKE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SNOWFLAKE INC (5Q5.DE) is 177.05 and the Price/Book (PB) ratio is 35.03.


What is the financial health of SNOWFLAKE INC (5Q5.DE) stock?

The financial health rating of SNOWFLAKE INC (5Q5.DE) is 5 / 10.